Capstone Therapeutics (CAPS) Stock Chart & Stock Price History $1.10 +0.09 (+8.91%) As of 04:00 PM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsEarningsHeadlinesSEC FilingsTrendsBuy This Stock Capstone Therapeutics Stock Price Performance The Capstone Therapeutics (CAPS) stock chart highlights key performance trends across multiple timeframes. In the past month, the stock has decreased 31.25%, reflecting recent market activity. As of the latest close, Capstone Therapeutics traded at $1.01 with a market cap of $162 thousand and volume of 30,088 shares. Receive CAPS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Capstone Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-11.29%1 Month Performance-31.25%3 Month Performance-42.41% CAPS Stock Chart for Friday, August, 22, 2025 CAPS Chart by TradingView Capstone Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/22/2025$1.01$1.10+8.91%$1.14$1.00111,544 shs$174,000.0008/21/2025$1.02$1.01-0.98%$1.03$0.9630,088 shs$162,000.0008/20/2025$1.09$1.02-6.42%$1.15$0.9860,464 shs$163,000.0008/19/2025$1.14$1.09-4.39%$1.16$1.0390,107 shs$172,000.0008/18/2025$1.24$1.14-8.06%$1.24$1.11151,808 shs$182,000.0008/15/2025$1.29$1.24-3.88%$1.46$1.22415,765 shs$198,000.0008/14/2025$1.25$1.29+3.20%$1.30$1.2244,013 shs$206,000.0008/13/2025$1.25$1.25$1.29$1.2423,600 shs$198,000.0008/12/2025$1.24$1.25+0.81%$1.30$1.2093,132 shs$200,000.0008/11/2025$1.32$1.24-6.06%$1.34$1.2220,595 shs$198,000.00 Get the Latest News and Ratings for CAPS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Capstone Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 08/08/2025$1.32$1.32$1.39$1.2956,234 shs$211,000.0008/07/2025$1.36$1.32-2.94%$1.49$1.2965,777 shs$209,000.0008/06/2025$1.40$1.36-2.86%$1.54$1.3639,307 shs$218,000.0008/05/2025$1.49$1.40-5.72%$1.50$1.3074,589 shs$224,000.0008/04/2025$1.44$1.49+3.13%$1.59$1.32253,633 shs$238,000.0008/01/2025$1.66$1.44-13.25%$1.69$1.29177,609 shs$230,000.0007/31/2025$1.67$1.66-0.60%$1.94$1.60567,147 shs$262,000.0007/30/2025$1.78$1.67-6.18%$2.00$1.60371,860 shs$267,000.0007/29/2025$1.56$1.78+14.10%$1.78$1.56101,745 shs$285,000.0007/28/2025$1.60$1.56-2.19%$1.63$1.5247,446 shs$246,000.0007/25/2025$1.60$1.60-0.31%$1.64$1.5816,998 shs$252,000.0007/24/2025$1.68$1.60-4.76%$1.68$1.6039,953 shs$256,000.0007/23/2025$1.60$1.68+5.00%$1.74$1.5965,224 shs$269,000.0007/22/2025$1.62$1.60-1.23%$1.62$1.575,297 shs$253,000.0007/21/2025$1.62$1.62$1.63$1.5635,039 shs$259,000.00 Related Companies PBLA Stock Price Chart HEPA Stock Price Chart BPTSY Stock Price Chart VIRX Stock Price Chart TRVN Stock Price Chart MYMD Stock Price Chart BON Stock Price Chart VINC Stock Price Chart NCNA Stock Price Chart ORGS Stock Price Chart Receive CAPS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Capstone Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CAPS) was last updated on 8/22/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon Musk’s New TechnologyElon Musk is building something in Memphis that could eclipse even Tesla and SpaceX. At the heart of it is a n...Paradigm Press | SponsoredBREAKING: The House just passed 3 pro-crypto bills!The “top secret” DeFi play Our #1 Coin Report reveals which protocol is building this institutional bridge...Crypto 101 Media | SponsoredGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | SponsoredNew law could create $3.7 trillion tsunami.During a meeting in Washington D.C., Jeff Brown discovered a bold initiative. He calls it “President Trump’...Brownstone Research | SponsoredTax Drain Deadline: Protect Your Wealth Before September 15thOn September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredA grave, grave error.Nvidia just shattered records—hitting $4 trillion in valuation faster than any company in history. But one ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Capstone Therapeutics Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Capstone Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access